Format

Send to

Choose Destination
BMJ Evid Based Med. 2018 Jun;23(3):111-112. doi: 10.1136/bmjebm-2018-110935. Epub 2018 Mar 29.

Proton pump inhibitor therapy after Helicobacter pylori eradication may increase the risk of gastric cancer.

Author information

1
Department of Medicine, Michael E. DeBakey VA Medical Center, Baylor College of Medicine, Houston, Texas, USA.

KEYWORDS:

gastroenterology; gastrointestinal infections; gastrointestinal tumours

PMID:
29599181
DOI:
10.1136/bmjebm-2018-110935
[Indexed for MEDLINE]

Conflict of interest statement

Competing interests: DYG is supported by Public Health Service grant DK56338, which funds the Texas Medical Center Digestive Diseases Center. DYG is a consultant for RedHill Biopharma regarding novel Helicobacter pylori therapies and has received research support for culture of H. pylori and is the PI of an international study of the use of antimycobacterial therapy for Crohn’s disease. He is also a consultant for BioGaia in relation to probiotic therapy for H. pylori infection and for Takeda in relation to H. pylori therapies.

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center